Citation

Murugesan N, Gu Z, Spergel S, Young M, Chen P, Mathur A, Leith L, Hermsmeier M, Liu EC, Zhang R, Bird E, Waldron T, Marino A, Koplowitz B, Humphreys WG, Chong S, Morrison RA, Webb ML, Moreland S, Trippodo N, Barrish JC.: Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist. J Med Chem, Volume 46 (1), 2003

Authors

Barrish JC., Bird E, Chen P, Chong S, Gu Z, Hermsmeier M, Humphreys WG, Koplowitz B, Leith L, Liu EC, Marino A, Mathur A, Moreland S, Morrison RA, Murugesan N, Spergel S, Trippodo N, Waldron T, Webb ML, Young M, Zhang R

Journal

J Med Chem

Year

2003

DOI

10.1021/jm020289q

PubMed

12502366

Machine-readable

REST APIRDF